 | Avenue Therapeutics (NASDAQ:ATXI) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - August 15 at 12:44 PM |
 | Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 14 at 9:00 AM |
| Avenue Therapeutics Inc (NASDAQ:ATXI) CFO Joseph Walter Vazzano Sells 4,688 Shares
www.americanbankingnews.com - August 12 at 6:53 PM |
| Short Interest in Avenue Therapeutics Inc (NASDAQ:ATXI) Declines By 32.0%
www.americanbankingnews.com - August 12 at 6:32 PM |
| Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors
finance.yahoo.com - August 1 at 11:22 AM |
| Avenue Therapeutics Inc (NASDAQ:ATXI) Short Interest Down 29.9% in July
www.americanbankingnews.com - July 27 at 10:49 AM |
| Brokerages Expect Avenue Therapeutics Inc (NASDAQ:ATXI) Will Announce Earnings of -$0.57 Per Share
www.americanbankingnews.com - July 27 at 2:18 AM |
| 3 Foolproof Strategies To Minimize Risk
finance.yahoo.com - June 8 at 9:30 AM |
| Avenue Therapeutics Trades Higher After Phase 3 Success
finance.yahoo.com - June 3 at 5:43 PM |
| Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
finance.yahoo.com - June 3 at 9:37 AM |
| Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 13 at 9:47 AM |
| Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors
finance.yahoo.com - April 30 at 9:36 AM |
 | Plenty Of Further Upside In Fortress Biotech
seekingalpha.com - March 19 at 10:02 AM |
| Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 12 at 11:06 AM |
| Earn Outsized Alpha With Avenue Therapeutics
seekingalpha.com - February 7 at 9:44 AM |
 | Topline data readout expected in mid-2019
globenewswire.com - December 19 at 9:44 AM |
| SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Avenue Therapeutics, Inc. - ATXI
finance.yahoo.com - December 13 at 9:02 AM |
| ATXI: InvaGen Acquisition Spices Up Quarterly Report
finance.yahoo.com - December 3 at 9:40 AM |
| Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
finance.yahoo.com - November 15 at 9:25 AM |
| Avenue Therapeutics, Inc. (ATXI) InvaGen Announces Acquisition Agreement with Avenue Therapeutics Conference Call (Transcript)
seekingalpha.com - November 14 at 4:23 PM |
| ATXI: InvaGen Capital Raise & Acquisition
finance.yahoo.com - November 13 at 4:25 PM |
| Avenue Therapeutics up 31% premarket on takeover by InvaGen
seekingalpha.com - November 13 at 9:11 AM |
| Avenue Therapeutics up 95% on dim Ad Com prospects for Trevena's oliceridine
seekingalpha.com - October 11 at 4:11 PM |
| Avenue Therapeutics down 15%
seekingalpha.com - September 17 at 4:22 PM |
| ATXI: Second Quarter 2018 Results
finance.yahoo.com - August 27 at 4:16 PM |
| Biotech incubator taps investors through in-house brokerage
finance.yahoo.com - August 2 at 10:10 AM |
| Avenue Therapeutics Is On To Something
seekingalpha.com - June 26 at 11:23 AM |
| ATXI: KOL Call with Drs. Singla and Minkowitz on IV Tramadol
finance.yahoo.com - June 12 at 4:16 PM |
| Avenue Therapeutics up 32% premarket on positive late-stage results for pain med IV tramadol
seekingalpha.com - May 21 at 9:27 AM |
| ATXI: 1Q:18 Update Confirms Timeline
finance.yahoo.com - May 14 at 10:34 AM |
| ATXI: No Pain? We See a Gain; Developing Tramadol
finance.yahoo.com - April 10 at 4:18 PM |
| Avenue Therapeutics to Present at March Investor Conferences
finance.yahoo.com - March 5 at 9:57 AM |
| Avenue Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Highlights
finance.yahoo.com - March 1 at 9:21 AM |
| Avenue Therapeutics to Participate in Panel on Opioid Abuse at BIO CEO & Investor Conference
finance.yahoo.com - February 6 at 9:00 AM |
| Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial of Intravenous Tramadol for the Management of Postoperative Pain
finance.yahoo.com - January 2 at 8:50 AM |
| Avenue Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
finance.yahoo.com - November 9 at 5:21 PM |
 | Weekly Top Insider Buys Highlight for the Week of Oct. 13
www.nasdaq.com - October 15 at 3:56 PM |
 | Avenue Therapeutics (ATXI) Doses First Patient in Pivotal Phase 3 ... - StreetInsider.com
www.streetinsider.com - September 28 at 12:51 AM |
